Patent intelligence · WO
WO 2021152186
ANTICORPS CCR8 POUR APPLICATIONS THÉRAPEUTIQUES
ANTICORPS CCR8 POUR APPLICATIONS THÉRAPEUTIQUES
Patent details — WO 2021152186
- Jurisdiction
- WO
- Status
- granted
- Grant date
- Aug 5, 2021
- Expiration
- Jul 31, 2041
- Applicant
- BAYER AG [DE]
- CPC classes
- A61K/31337, A61K/31555, A61K/31704, A61K/393955
Quick answer
WO 2021152186 (ANTICORPS CCR8 POUR APPLICATIONS THÉRAPEUTIQUES) is held by BAYER AG [DE]. Status: granted. Granted Aug 5, 2021. Expires Jul 31, 2041 (15 years remaining) — relevant for patent-cliff and LOE planning.
Key facts
- Applicant
- BAYER AG [DE]
- Grant date
- Expiration
- Claims
- —
- CPC classes
- A61K/31337, A61K/31555, A61K/31704, A61K/393955, A61K/4506, A61K/476849
More from BAYER AG [DE]
Related pharmaceutical patents in our USPTO index.
-
WO 2024052517
USAGE MÉDICAL D'ANTICORPS ANTI-CCR8 ET PROGRAMME DE DOSAGE
granted -
CN 117186084
Pranlerivir sulfonate, and pharmaceutical preparation, preparation method and application thereof in treatment of herpes virus
granted -
CN 115348859
Ophthalmic formulations comprising n-[5-(aminosulfonyl)-4-methyl-1, 3-thiazol-2-yl]-n-methyl-2-[4-(2-pyridinyl) phenyl] acetamide hemihydrate
granted -
CN 115003329
Parapoxvirus for conditioning and treating coronavirus infections
granted -
BR 112021015776
Edição de gene para hemofilia a com expressão de fator viii melhorada
granted -
DE 102019218587
Kontrastmittelbasierte Gefäßdarstellung
granted -
DE 102019218589
Simultane Bilddarstellung von zwei unterschiedlichen funktionellen Bereichen
granted
Frequently asked questions
What is US patent 2021152186?
WO 2021152186 (ANTICORPS CCR8 POUR APPLICATIONS THÉRAPEUTIQUES) is held by BAYER AG [DE]. Status: granted. Granted Aug 5, 2021. Expires Jul 31, 2041 (15 years remaining) — relevant for patent-cliff and LOE planning.
Who owns WO 2021152186?
BAYER AG [DE] is listed as the applicant in USPTO PatentsView records indexed by NovaPharmaNews. We track 24 pharmaceutical patents for this assignee.
When does WO 2021152186 expire?
Our index shows an expiration date of Jul 31, 2041 (15 years from today). Confirm material dates against USPTO, FDA Orange Book, or qualified counsel before contractual decisions.